Is stem cell therapy something we should be considering at an early stage of progression?

In this video Polly interviews Dr Paolo Muraro who is a Neurologist. The interview was filmed by Shift.ms

Video transcript

Polly: Is stem cell therapy something we should be considering at an early stage of progression?


Dr Paolo Muraro, Neurologist: Yes, for any therapy in MS, the earlier the better, but I think the window of opportunity may extend into the earliest part of the progressive phase for those who have secondary progressive disease. At that stage we know that there can be still active inflammation. We do have a number of markers, clinical and MRI, to establish whether that kind of inflammation is still ongoing and if so, there is still opportunity for intervention to stop the process and potentially reverse it.


Polly: So repair can still happen even if people have progressive conditions, it’s not that anything’s dead, it’s still just reparable?


Dr Paolo Muraro: Yes. There is, by the time progressive disease has started we know that unfortunately a lot of damage has already occurred and this makes things more difficult, but in the early stages of progression there is, on the one side, there is still spare capacity, and on the other side there is still some form of repair which is spontaneously occurring, although it’s ultimately on the way to failing and if we can try and find new ways to stop that failure and reverse the failure, then we can be successful at stopping progression.


Polly: Okay.



Join the Shift.ms community: https://shift.ms/


Watch more videos here:

https://shift.ms/msreporters
https://www.facebook.com/shift.ms/
https://www.instagram.com/shiftdotms/
https://twitter.com/shiftms

More videos about Research category

Leave a Reply

Have you found this video useful? Please let us know by filling in this short survey.
Join the Shift.ms communityclose